4-Nitro-2,3-lutidine-N-oxide

We are 4-Nitro-2,3-lutidine-N-oxide CAS:37699-43-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-Nitro-2,3-lutidine-N-oxide
CAS.NO:37699-43-7
Synonyms:4-Nitro-2,3-lutidine-N-oxide
2,3-DiMethyl-4-nitropyridine N-Oxide
2,3-dimethyl-4-nitro-pyridine oxide
4-NITRO-2,3-DIMETHYLPYRIDINE N-OXIDE
4-NITRO-2,3-LUTIDINE N-OXIDE
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 403.3±40.0 °C at 760 mmHg
Melting Point 94-98 °C(lit.)
Molecular Formula C7H8N2O3
Molecular Weight 168.150
Flash Point 197.7±27.3 °C
Vapour Pressure 0.0±0.9 mmHg at 25°C
Index of Refraction 1.574
 
Specification:
Appearance:Yellow crystalline powder
Assay:≥98.0%
Melting Point:89-93°C
Loss on drying:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Lansoprazole(CAS:103577-45-3)、Rebeprazole(CAS:117976-89-3) and Rebeprazole sodium(CAS:117976-90-6).

4-Nitro-2,3-lutidine-N-oxide


Related News: It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance.149198-47-0 The upstream of pharmaceutical intermediates is the basic chemical raw material industry. Basic chemical raw materials are bulk commodities and prices fluctuate greatly, which directly affects the production costs of enterprises.cytidine CAS:65-46-3 The upstream of pharmaceutical intermediates is the basic chemical raw material industry. Basic chemical raw materials are bulk commodities and prices fluctuate greatly, which directly affects the production costs of enterprises.1-fluoro-9-clorononane CAS:463-23-0 The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.Active pharmaceutical ingredients directly impact disease.

Related Products
Product Name
2-Chlorobenzothiazole View Details
3-Methyl-1,5-pentanediol View Details
4-Chloro-6-iodoquinazoline View Details
1-[2-(2-Hydroxyethoxy)Ethyl]Piperidine manufacturer N-((4-Chloromethyl)-2-thiozolyl)guanidine hydrochloride manufacturer ethyl 4-methoxy-3-oxobutanoate manufacturer 1-(2,3-difluorophenyl)ethanone manufacturer 6-Cyano-2-[1-(4-ethyl-3-iodophenyl)-1-methylethyl]-1H-indole-3-carboxylic acid 1,1-dimethylethyl ester manufacturer